Temporary interruption of anticoagulation therapy is usually recommended for anticoagulated patients undergoing invasive procedures to minimize their bleeding risks. We validated the current consensus recommendation on warfarin interruption which were based on Western population studies to determine if they could safely be applied to Asians. The international normalized ratios (INR) in twenty warfarinised patients with a stable INR of 2–3 were prospectively measured at days 0, 3 and 5 after stopping warfarin for procedures or at completion of treatment. The median INR at days 0, 3 and 5 were 2.30 (95% CI 2.16–2.43), 1.32 (95% CI 1.22–1.57) and 1.06 (95% CI 1.05–1.13) respectively (P < 0.001 for trend). All patients were below therapeutic INRs by day 3 with 14 patients (70%, 95% CI 49.92–90.08) achieving INR readings below 1.5. By day 5, all INRs were below 1.5 and only 2 patients (10%, 95% CI −3.15 to 23.15) had INRs above 1.2. There were no significant peri-procedure bleeding or thrombotic events in the 1 month following interruption of warfarin. Our results suggest that the current international recommendation of stopping warfarin for 5 days prior to procedure can safely be applied to Asians without compromising risk of bleeding or thrombosis.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Palareti G, Legnani C (1996) Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 30(4):300–313
White RH, McKittrick T, Hutchinson R, Twitchell J (1995) Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 122(1):40–42
Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC et al (2008) The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):299S–339S
Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C et al (2007) Association of warfarin dose with genes involved in its action and metabolism. Hum Genet 121(1):23–34
Khan T, Wynne H, Wood P, Torrance A, Hankey C, Avery P et al (2004) Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br J Haematol 124(3):348–354
Committee for Medicinal Products for Human Use (CHMP) (2007) Guideline on clinical investigation of medicinal products for prophylaxis of high intra- and postoperative venous thromboembolic risk. 15 Nov 2007. http://www.emea.europa.eu/pdfs/human/ewp/70798en_fin.pdf
Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E et al (2009) Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 40(6):2276–2293
Schulman S, Elbazi R, Zondag M, O’Donnell M (2008) Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study. Thromb J 6:15
Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ (2001) Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med 135(6):393–400
Jonas DE, McLeod HL (2009) Genetic and clinical factors relating to warfarin dosing. Trends Pharmacol Sci 30(7):375–386
Zhao F, Loke C, Rankin SC, Guo JY, Lee HS, Wu TS et al (2004) Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose. Clin Pharmacol Ther 76(3):210–219
Singapore in figures (2008) Singapore Department of Statistics
Ballinger SW, Schurr TG, Torroni A, Gan YY, Hodge JA, Hassan K et al (1992) Southeast Asian mitochondrial DNA analysis reveals genetic continuity of ancient Mongoloid migrations. Genetics 130(1):139–152 Jan
Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La RL et al (2009) Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 119(22):2920–2927
This study was supported by a grant from the Singapore General Hospital Research Fund.
About this article
Cite this article
Koh, S.K., Ng, H.J., Kong, M.C. et al. Validity of current recommendation for peri-operative interruption of warfarin in Asians. J Thromb Thrombolysis 30, 354–357 (2010). https://doi.org/10.1007/s11239-010-0476-2
- Warfarin interruption
- INR normalization
- Invasive procedures